Why is KNCV Tuberculosis Foundation also known as KNCV TB Plus?

Tuberculosis (TB) does not exist in isolation. Persons with TB are vulnerable to a range of infectious diseases and are affected by socio-economic determinants of health. Together we can end TB. The goal of KNCV TB Plus is to use all our comprehensive expertise, our best practices, and drive health care innovations to work towards global health for all in a world free of TB and other related infectious diseases. Mustapha Gidado, Executive Director of KNCV TB Plus, explains further in this video.

OUR NEWS

  • KNCV TB PLUS

    Over 120 years of expertise and experience in fighting TB

    Together we can end TB!

  • 17/05/2023

    Saying goodbye and welcoming: two long esteemed colleagues

    Today we are saying goodbye to Jan Hendrik Richardus, Vice-Chair of the Board of Trustees (BoT) of…

    Lees meer

  • 06/04/2023

    Investing in TB vaccine research and development can save millions of lives

    Despite progress in TB control efforts, the global burden of TB remains high, with an estimated 10.6 million new cases…

    Lees meer

  • 04/04/2023

    Join us for a Round Table Discussion on BPaLM/BPaL

    On 12 April 2023, KNCV TB Plus will conduct an online Round Table Discussion on ‘Experience sharing: Preparation for programmatic…

    Lees meer

  • 30/03/2023

    KNCV Ethiopia’s Contributions and Recognition during the 17th Annual TB Research Conference (TRAC)

    KNCV TB Plus Ethiopia participated in 17th annual tuberculosis (TB) research conference (TRAC) and in the World TB Day commemoration, which…

    Lees meer

  • 24/03/2023

    250,000 patients to benefit from free access to short-course TB preventive treatment across seven countries

    Johannesburg, 24 March 2023 – The Unitaid-funded IMPAACT4TB Consortium, led by the Aurum Institute, announced today that it will…

    Lees meer
More news

Special Feature:

Success stories on shorter regimens

Enjoy reading the success stories from KNCV’s implementation of the IMPAACT4TB project: “Treatments such as the 3HP regimen can save your life.”

Our nine key intervention pathways

We fight against TB worldwide

KNCV is headquartered in The Hague, The Netherlands and we have offices in ten countries. Besides this we work with four affiliated offices in Indonesia, Nigeria, Kenya and Kyrgyzstan. We support programs around the world, funded by, among others by Unitaid, the Bill & Melinda Gates Foundation, the Dutch Ministry of Foreign Affairs (DGIS), Global Fund (GF), TB REACH and industry (Cepheid).

Netherlands
Ethiopia
Kazakhstan
KNCV Kyrgyzstan
KNCV Nigeria
Malawi
Tajikistan
Tanzania
The Philippines
Vietnam
Cambodia
Eswatini
Ghana
Namibia
Rwanda
South Africa
Ukraine
Uzbekistan
Zambia
Indonesia
KNCV Kenya
Kyrgyzstan
Nigeria
  • KNCV Central Offices
  • KNCV country offices
  • KNCV assists as technical partner
  • KNCV Affiliates

Patient stories

"It all started when Abdurahim was two. He suddenly stopped walking and couldn’t even sit, he would just lie down day and night and was simply unable to stand."
“If I don’t get my medicines, I may not die from corona, but I will die from TB”
“Giving a stool sample is of course no trouble and does not hurt. It would be great if children only had to undergo this test in the future.”
"I used to cry a lot and begged to God that he would help me and the kids. I asked if he could give them a great life. It helped, the pills worked and we all got better.”
“During the first few weeks I couldn’t calm down, my whole family was infected with TB”, says Olga holding Maxime to her chest.
“Me and my sister were always close, she helped me with my youngest baby and we support each other with everything” Saanvi (26)
Bezoek Nederlandse website

KNCV has been fighting TB since its establishment in 1903. Over the past 120 years, the organization has acquired indispensable knowledge and experience in the field of effective TB prevention and care, resulting in pre-elimination in the Netherlands and significant contributions to global evidence generation, policy development and TB program implementation worldwide.

Our experts
KNCV governance framework and integrity
Our patroness
Partner with us

Cambodia
Eswatini
Ethiopia
Indonesia
Kazakhstan
Kenya
Kyrgyzstan
Namibia
Nigeria
Tajikistan
Tanzania
Ukraine
Vietnam
Zambia

Tuberculosis is still one of the major causes of preventable death in the world and claims over 4000 lives a day, leading to over 1,5 million deaths a year.

Patient stories

The story of Abdurahim
The story of Fikeraddis
The story of Issayas
The story of Zarina
The story of Maxine
The story of Saanvi

KNCV’s Technical Assistance Strategy

New drugs & treatment regimens
Digital health solutions
Diagnosis & treatment of LTBI
TB Stigma reduction
Epidemiological measurement methodologies
New diagnostics and lab network design
People-Centred Framework for National Strategic Planning and HSS
Blended learning platform & methodologies

ASCENT
ASTTIE
Development of a comprehensive Digital Training Package
E-detect
GeneXpert MTB/RIF Test
IMPAACT4TB
PAVIA
People-Centered Framework for TB Programming
PODTEC
TB Alliance BPAL Project
The Global Fund to Fight AIDS, Tuberculosis and Malaria
TREATS

Our success stories

Challenge TB
Improved TB/HIV Prevention & Care – Building Models for the Future Project
TB REACH Ethiopia
TB REACH Nigeria
TB REACH Philippines
TB REACH Tanzania

KNCV Webinar: Impact of COVID-19: Hear the perspective of TB/MDR-TB patients and front line health care workers
KNCV Webinar: Contact Investigation for COVID-19: Lessons from TB Control Programs
KNCV Webinar ‘Infection prevention and control for COVID-19

Annual Report 2020
KNCV 2-pager ASCENT
KNCV 2-pager Childhood TB
KNCV 2-pager Digital Health
KNCV 2-pager General
KNCV 2pager Right Diagnosis, Right Treatment
KNCV 2-pager TB Photovoices
KNCV 2-pager TB Stigma

Sorry

De versie van de browser die je gebruikt is verouderd en wordt niet ondersteund.
Upgrade je browser om de website optimaal te gebruiken.